Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a glucagon-like peptide-1 receptor agonist, reduces appetite and slows stomach emptying to produce significant weight loss—typically 10-15% of body weight over six months in clinical trials. The medication begins at a low starting dose and increases over time, a process called titration, to minimize side effects while achieving your target dose. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, with pricing that stays flat regardless of your dose level.

Understanding Semaglutide Dosing Schedules

Semaglutide dosing follows a four-week titration schedule, meaning your dose increases every 28 days until reaching a maintenance level. The typical progression moves from 0.25 mg in week one, up to 0.5 mg in week five, 1.0 mg in week nine, and continuing to 2.4 mg by week 17. This gradual approach allows your gastrointestinal system to adapt, reducing nausea and other adjustment-related side effects that can occur with faster dose escalation.

Your personal target dose depends on your weight loss goals, how well you tolerate the medication, and your individual metabolic response. Some patients reach effective results at 1.0 or 1.7 mg weekly, while others benefit from the maximum 2.4 mg dose. PlexusDx works with you to identify your optimal dose without changing your monthly price, honoring the principle that your commitment cost remains stable as your treatment advances.

How Semaglutide Doses Affect Weight Loss Results

Clinical data shows dose-dependent weight loss, with higher doses producing greater results on average. Patients on 2.4 mg semaglutide lost approximately 15% of their starting body weight, compared to 10-12% at lower doses like 1.0 mg, according to major randomized trials. However, individual response varies significantly—some people achieve meaningful loss at 1.7 mg while others need the full 2.4 mg to see desired results.

The relationship between dose and benefit isn't linear, meaning doubling your dose doesn't double your weight loss. Instead, researchers observe a plateau effect where additional dose increases yield smaller incremental gains, though they may still provide meaningful clinical benefit. Your genetic profile influences how your body responds to semaglutide, which is why PlexusDx offers the Precision Peptide Genetic Test to map your peptide pathways and predict treatment responsiveness.

Starting Low and Going Slow: The Titration Advantage

Beginning at the lowest semaglutide dose of 0.25 mg allows your body to adjust to the medication's appetite-suppressing effects while minimizing gastrointestinal discomfort. This 'start low, go slow' approach prevents overwhelming side effects that can lead to treatment discontinuation, ensuring you stay engaged with your weight loss journey. Studies confirm that gradual titration improves medication adherence and long-term weight loss outcomes compared to higher starting doses.

During titration weeks, you'll typically experience reduced hunger signals, earlier fullness during meals, and decreased cravings for high-calorie foods. These effects build gradually as your dose increases, giving you time to adjust your eating patterns and develop sustainable new habits. PlexusDx provides clinical support throughout your titration period to monitor your progress and make dose adjustments that align with your tolerance and goals.

Maintenance Dosing and Long-Term Weight Loss

Once you reach your target semaglutide dose, you enter the maintenance phase where you continue the same dose weekly to sustain weight loss results. Most patients maintain effectiveness on their chosen dose for months or years, though some gradually require dose increases if their appetite suppression effect diminishes over time. Maintenance dosing typically occurs at 1.7 mg or 2.4 mg weekly, though individual needs vary based on your metabolic response and weight loss trajectory.

Long-term semaglutide use requires ongoing medical supervision and lifestyle support to prevent weight regain if treatment is discontinued. PlexusDx patients benefit from continuous access to clinical guidance, genetic insights from the Precision Peptide Genetic Test, and flexible pricing across all dose levels—your monthly cost remains flat whether you're at 0.25 mg or 2.4 mg. This model removes financial barriers to reaching and maintaining your optimal therapeutic dose.

Personalized Dosing With Genetic Insights

Your genetic makeup influences how effectively semaglutide works in your body, particularly variants in the GLP1R gene (rs6923761) that affect receptor sensitivity and medication response. PlexusDx's Precision Peptide Genetic Test analyzes 14 peptide pathways and 150+ genetic insights, including key variants like GIPR rs1800437 and MC4R rs17782313 that shape your appetite regulation and weight loss potential. This personalized approach helps predict which dose level will likely produce optimal results for your unique biology.

Genetic testing informs your starting dose strategy and expected response timeline, allowing PlexusDx clinicians to tailor your titration schedule and target dose recommendations. Patients with certain genetic profiles may reach effective weight loss at lower doses, while others benefit from reaching the maximum 2.4 mg dose. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, providing data-driven personalization that optimizes your semaglutide therapy from the start.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected subcutaneously once weekly, taken for four weeks before increasing. This low initial dose minimizes gastrointestinal side effects while allowing your body to adapt to the medication's appetite-suppressing effects. PlexusDx compounded semaglutide injections begin at $149 per month regardless of your dose level.

How quickly does semaglutide dosing increase?

Semaglutide typically increases every four weeks on a standard schedule: 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg. Your PlexusDx clinician may adjust the pace based on your tolerance and side effects, potentially spacing increases further apart if needed. This gradual titration approach produces better long-term adherence and weight loss outcomes than faster dose escalation.

Will my PlexusDx price increase when my semaglutide dose goes up?

No. PlexusDx pricing remains flat across all semaglutide doses—your cost stays $149 per month whether you're taking 0.25 mg or 2.4 mg weekly. This flat-rate model eliminates financial barriers to reaching your optimal therapeutic dose and reflects the PlexusDx commitment that your dose may need to go up, but your price won't.

What are typical side effects at different semaglutide doses?

Early doses often cause mild nausea, reduced appetite, and occasional constipation, which typically improve within days as your body adapts. Higher maintenance doses may produce more pronounced appetite suppression and gastrointestinal effects, though these are generally manageable with dietary adjustments. Serious adverse events are rare, but PlexusDx clinicians monitor your experience throughout treatment and can adjust your dose if side effects become bothersome.

How does genetic testing predict my semaglutide dose response?

The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your appetite regulation and medication responsiveness. Patients with certain genetic profiles may achieve weight loss goals at 1.0-1.7 mg doses, while others require the full 2.4 mg dose for optimal results. Testing for $99 after your first month provides personalized insights that help optimize your dosing strategy from the beginning.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves